Dexmedetomidine‐Induced Aortic Contraction Involves Transactivation of the Epidermal Growth Factor Receptor in Rats

Dexmedetomidine‐Induced Aortic Contraction Involves Transactivation of the Epidermal Growth Factor Receptor in Rats

Show other versions (1)

In this study, we examined whether aortic contraction, induced by the alpha‐2 adreno-ceptor agonist dexmedetomidine, is involved in the transactivation of the epidermal growth factor receptor (EGFR) in isolated endothelium‐denuded rat aortas. Additionally, we aimed to elucidate the associated underl...

Full description

Bibliographic Details
Main Authors:	Ahn, S.H (Author), Bae, S.I (Author), Hwang, Y. (Author), Kim, J.-Y (Author), Kim, M. (Author), Kwon, S.-C (Author), Lee, S.H (Author), Ok, S.-H (Author), Park, K.-E (Author), Sohn, J.-T (Author)
Format:	Article
Language:	English
Published:	MDPI 2022
Subjects:	alpha‐2 adrenoceptor contraction dexmedetomidine epidermal growth factor receptor transactivation
Online Access:	View Fulltext in Publisher

Similar Items

Dexmedetomidine‐Induced Aortic Contraction Involves Transactivation of the Epidermal Growth Factor Receptor in Rats
by: Ahn, S.H, et al.
Published: (2022)

Dexmedetomidine: Expanding role in anesthesia
by: Jyotsna S Paranjpe
Published: (2013-01-01)

Age-related effects of dexmedetomidine on myocardial contraction and coronary circulation in isolated guinea pig hearts
by: Maiko Hongo, et al.
Published: (2016-06-01)

Bidirectional effects of dexmedetomidine on human platelet functions in vitro
by: Kawamoto, Shuji
Published: (2016)

GPCR transactivation signalling in vascular smooth muscle cells: role of NADPH oxidases and reactive oxygen species
by: Raafat Mohamed, et al.
Published: (2019-08-01)

Dexmedetomidine ameliorates memory impairment in sleep-deprived mice
by: Lakkyong Hwang, et al.
Published: (2019-11-01)

Dexmedetomidine enhances tolerance to bupivacaine cardiotoxicity in the isolated rat hearts: alpha 2 adrenoceptors were not involved
by: Fangfang Xia, et al.
Published: (2019-11-01)

USING DEXMEDETOMIDINE AS THE MAIN AGENT FOR ANESTHETIC MANAGEMENT DURING RADIOSURGERY IN A CHILD
by: A. M. Аrefiev, et al.
Published: (2019-01-01)

Bradycardia and Severe Bispectral Index Drop Following Femoral Nerve Block by Dexmedetomidine due to Accidental Vascular Puncture: A Case Report
by: Elham Memary, et al.
Published: (2016-11-01)

Epidermal Growth Factor Receptor Transactivation Is Required for Mitogen-Activated Protein Kinase Activation by Muscarinic Acetylcholine Receptors in HaCaT Keratinocytes
by: Wymke Ockenga, et al.
Published: (2014-11-01)

Reduction of sevoflurane and fentanyl consumption through dexmedetomidine use as a part of general anesthesia in oncogynecological surgery (a prospective blind randomized study)
by: K. A. Tsygаnkov, et al.
Published: (2019-11-01)

Dexmedetomidine in anesthesia of children submitted to videolaparoscopic appendectomy: a double-blind, randomized and placebo-controlled study Dexmedetomidina na anestesia de crianças submetidas à apendicectomia por videolaparoscopia: um estudo duplo cego randomizado e placebo-controlado
by: Maria Cristina Smania, et al.
Published: (2008-08-01)

Dexmedetomidine-induced contraction of isolated rat aorta is dependent on extracellular calcium concentration
by: Seong-Ho Ok, et al.
Published: (2012-09-01)

The α2-Adrenoceptor Agonist Dexmedetomidine in Current Sedation Practice
by: I. A. Kozlov
Published: (2013-04-01)

Mechanisms involved in PGE<sub>2</sub>-induced transactivation of the epidermal growth factor receptor in MH<sub>1</sub>C<sub>1</sub> hepatocarcinoma cells
by: Tveteraas Ingun, et al.
Published: (2012-09-01)

Lysophosphatidic Acid–Induced EGFR Transactivation Promotes Gastric Cancer Cell DNA Replication by Stabilizing Geminin in the S Phase
by: Haile Zhao, et al.
Published: (2021-09-01)

Multivalent and Bidirectional Binding of Transcriptional Transactivation Domains to the MED25 Coactivator
by: Heather M. Jeffery, et al.
Published: (2020-08-01)

Conserved Structural Motifs at the C-Terminus of Baculovirus Protein IE0 are Important for its Functions in Transactivation and Supporting hr5-mediated DNA Replication
by: Neta Luria, et al.
Published: (2012-05-01)

Upregulation of μ-Opioid Receptor in the Rat Spinal Cord Contributes to the α2-Adrenoceptor Agonist Dexmedetomidine-Induced Attenuation of Chronic Morphine Tolerance in Cancer Pain
by: Zhang P, et al.
Published: (2020-10-01)

Prevention of etomidate-induced myoclonus during anesthetic induction by pretreatment with dexmedetomidine
by: H.F. Luan, et al.
Published: (2015-02-01)

Research Note: Characterization of S-Meq containing the deletion in Meq protein's transactivation domain in a Marek's disease virus strain in Japan
by: Shiro Murata, et al.
Published: (2021-11-01)

Targeting PAR2 Overcomes Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells Through Inhibition of EGFR Transactivation
by: Yuhong Jiang, et al.
Published: (2021-04-01)

Cell-Surface Receptors Transactivation Mediated by G Protein-Coupled Receptors
by: Fabio Cattaneo, et al.
Published: (2014-10-01)

The Influence of Quadruplex Structure in Proximity to P53 Target Sequences on the Transactivation Potential of P53 Alpha Isoforms
by: Otília Porubiaková, et al.
Published: (2019-12-01)

Dissecting the transactivation domain (tAD) of the transcription factor c‐Myb to assess recent models of tAD function
by: Guro Næs, et al.
Published: (2020-11-01)

Comparison of the Sedative Effect and Recovery Time of Dexmedetomidine and Fentanyl during Elective Colonoscopy
by: Sh Rajaei, et al.
Published: (2018-10-01)

Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway
by: Yiheng Wang, et al.
Published: (2016-06-01)

Optimal dose of dexmedetomidine for sedation during spinal anesthesia
by: Hwoe-Gyeong Ok, et al.
Published: (2013-05-01)

Comparative Effects of R- and S-equol and Implication of Transactivation Functions (AF-1 and AF-2) in Estrogen Receptor-Induced Transcriptional Activity
by: Mylène Potier, et al.
Published: (2010-03-01)

The effects of intravenous dexmedetomidine on spinal anesthesia: comparision of different dose of dexmedetomidine
by: Mi Hyeon Lee, et al.
Published: (2014-10-01)

Dexmedetomidine combined with midazolam vs. dexmedetomidine alone for sedation during spinal anesthesia
by: Douk-Keun Yoon, et al.
Published: (2016-10-01)

The effects of different loading doses of dexmedetomidine on sedation
by: Jae Hwan Sim, et al.
Published: (2014-07-01)

Unraveling the molecular mechanisms of the class II transactivator, CIITA in skeletal muscle
by: Londhe, Priya V.
Published: (2013)

Dexmedetomidine-Induced Contraction Involves CPI-17 Phosphorylation in Isolated Rat Aortas
by: Seong-Ho Ok, et al.
Published: (2016-09-01)

A novel local anesthetic system: transcriptional transactivator peptide-decorated nanocarriers for skin delivery of ropivacaine
by: Chen CY, et al.
Published: (2017-06-01)

Graded or threshold response of the tet-controlled gene expression: all depends on the concentration of the transactivator
by: Heinz Niels, et al.
Published: (2013-01-01)

Effect of intrathecal dexmedetomidine versus intravenous dexmedetomidine on subarachnoid anesthesia with hyperbaric bupivacaine
by: Anshu Sharma, et al.
Published: (2020-01-01)

Real-time monitoring of PtaHMGB activity in poplar transactivation assays
by: José M. Ramos-Sánchez, et al.
Published: (2017-06-01)

Premedication with dexmedetomidine to reduce emergence agitation: a randomized controlled trial
by: Jong Chan Kim, et al.
Published: (2019-08-01)

Lipid Emulsion Enhances Vasoconstriction Induced by Dexmedetomidine in the Isolated Endothelium-Intact Aorta
by: Soo Hee Lee, et al.
Published: (2021-03-01)